42-9893-82
antibody from Invitrogen Antibodies
Targeting: MUC1
ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 42-9893-82 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD227 (Mucin 1) Monoclonal Antibody (SM3), eFluor™ 615, eBioscience™
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Description: This SM3 monoclonal antibody reacts with the under-glycosylated form of human Mucin 1 (MUC1, CD227), a large glycoprotein belonging to the mucin protein family. Mucin 1 contains a polypeptide core consisting of multiple tandem repeats that become highly glycosylated. Mucin 1 is typically expressed in ductal or glandular epithelial cells and is localized to the apical membrane. In cancerous cells, Mucin 1 expression is increased and membrane-specific localization is lost resulting in expression throughout the membrane and cytoplasm. High levels of under-glycosylated Mucin 1 are thought to affect cell behavior during both invasion and metastasis as well as in immune recognition. In addition, under-glycosylated Mucin 1 is shed from the epithelial cell surface and can be detected in circulation. Alterations in Mucin 1 glycosylation are found in most adenocarcinomas of the breast, lung, pancreas, prostate, and ovary. Mucin 1 has recently been shown to co-localize and interact with members of the erbB receptor kinase family, proteins that are upregulated in more aggressive forms of breast cancer.
- Antibody clone number
- SM3
- Concentration
- 0.2 mg/mL
Submitted references Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells.
Palange AL, Di Mascolo D, Carallo C, Gnasso A, Decuzzi P
Nanomedicine : nanotechnology, biology, and medicine 2014 Jul;10(5):991-1002
Nanomedicine : nanotechnology, biology, and medicine 2014 Jul;10(5):991-1002
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry on formalin-fixed paraffin embedded human breast carcinoma using 20 µg/mL of Mouse IgG1 Isotype Control eFluor® 615 (left) or 20 µg/mL Anti-Human CD277 (Mucin 1) eFluor® 615 (right). Nuclei are counterstained with DAPI.